Online Medical Services

Search documents
POMDOCTOR LIMITED Announces Full Exercise and Closing of Underwriter's Over-Allotment Option
Prnewswire· 2025-10-10 21:15
Core Viewpoint - POMDOCTOR LIMITED has successfully completed its initial public offering (IPO) with the underwriter exercising the option to purchase an additional 750,000 American Depositary Shares (ADSs) at a price of $4.00 per ADS, resulting in total gross proceeds of $23,000,016 before expenses [1]. Group 1: Offering Details - The IPO included an over-allotment option that was fully exercised, leading to the issuance of 750,000 additional ADSs [1]. - The total gross proceeds from the offering, including the over-allotment, amounted to $23 million [1]. - The ADSs began trading on the Nasdaq Global Market under the ticker symbol "POM" on October 8, 2025 [1]. Group 2: Company Overview - POMDOCTOR LIMITED is a leading online medical services platform in China, focusing on chronic disease management and pharmaceutical services [4]. - The company ranks sixth in China's Internet hospital market based on the number of contracted doctors as of 2022 [4]. - POMDOCTOR aims to enhance the efficiency and transparency of the healthcare value chain by connecting patients, doctors, and pharmaceutical products [4].
Pepco Holdings, Inc. and POMDOCTOR LIMITED Prepare for IPOs
Financial Modeling Prep· 2025-10-10 15:03
Group 1: Pepco Holdings, Inc. IPO - Pepco Holdings, Inc. is preparing for an initial public offering (IPO) on NASDAQ, planning to offer 5 million shares at a price of $4 each [1] - The IPO strategy mirrors that of POMDOCTOR LIMITED, which is also offering 5 million American Depositary Shares (ADSs) at the same price [1] Group 2: POMDOCTOR LIMITED IPO Details - POMDOCTOR LIMITED's IPO aims to raise approximately $20 million before expenses, with underwriters having the option to purchase an additional 750,000 ADSs within 45 days, potentially increasing total proceeds [2] - The ADSs will trade on the Nasdaq Global Market under the ticker "POM" starting October 8, 2025 [3] Group 3: POM Stock Performance - The current price of NYSE:POM is $14,500, reflecting a decrease of 1.03% or $150, with a trading range today between $14,350 and $14,650 [3] - Over the past year, POM has experienced significant price fluctuations, with a high of $21,500 and a low of $12,250, indicating volatility [3] - The trading volume for POM is 225,100 shares, suggesting active interest and liquidity in the market [3]
PomDoctor Debuts On Nasdaq Ahead Of New Listing Rules
Benzinga· 2025-10-10 09:57
The online medical services provider raised about $20 million after pricing its shares at the bottom of their range – below a Nasdaq-proposed new minimum threshold of $25 millionKey Takeaways:PomDoctor priced its IPO shares at the bottom of their range, seeking a high P/S ratio of nearly 10 that values the company at $472 millionThe company was racing to complete its listing before the rollout of new Nasdaq rules that will require all new foreign listings to raise at least $25 millionJust last month we wrot ...
POMDOCTOR LIMITED Announces Closing of Initial Public Offering
Prnewswire· 2025-10-09 20:05
, /PRNewswire/ -- POMDOCTOR LIMITED (Nasdaq: POM) (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announced the closing of its initial public offering (the "Offering") of 5,000,004 American Depositary Shares ("ADSs") at a public offering price of US$4.00 per ADS. Six ADSs represent one Class A ordinary share, par value US$0.0001 per share, of the Company. The ADSs began trading on Nasdaq Global Market on October 8, 2025 under the ticker symbol ...